{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["47(3)"],"submitter":["Fikkert V"],"journal":["Antimicrobial agents and chemotherapy"],"pagination":["1177-1177"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC149344"],"repository":["biostudies-literature"],"pubmed_title":["env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors"],"pmcid":["PMC149344"],"pubmed_authors":["Van Laethem K","Cherepanov P","Vandamme A","Van Remoortel B","Clercq E","Debyser Z","Witvrouw M","Pannecouque C","Fikkert V","Hantson A"],"additional_accession":[]},"is_claimable":false,"name":"env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors","description":null,"dates":{"release":"2003-01-01T00:00:00Z","publication":"2003 Mar","modification":"2025-04-04T07:10:44.909Z","creation":"2025-02-19T03:17:35.045Z"},"accession":"S-EPMC149344","cross_references":{}}